Certified by Founder Lodge
Kurma Partners
France - Paris, Paris
INVESTOR
1 Disclosed Funding Rounds $14,955,000
9 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (cu
| Company | Date | Round | Raised |
|---|---|---|---|
 Poppins |
April, 29 ,2025 | Unknown | $5,697,525 |
 Kiro |
April, 03 ,2023 | Series A | $14,955,000 |
 Elkedonia |
June, 11 ,2025 | Seed | $12,580,054 |
 Corteria Pharmaceuticals |
September, 07 ,2023 | Series A | $69,471,000 |
 Spotlight Medical |
July, 12 ,2024 | Seed | $6,760,573 |
 Coave Therapeutics |
January, 09 ,2025 | Series A | $32,000,000 |
| Poppins |
April, 29 ,2025 | Unknown | $5,697,525 |
| Elkedonia |
June, 11 ,2025 | Seed | $12,580,054 |
 Alveus Therapeutics Inc |
January, 09 ,2026 | Series A | $160,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Manufact (formerly mcp-use) | $6,300,000 | (Feb 13, 2026)
CYDELPHI | $3,000,000 | (Feb 13, 2026)
Integrate | $17,000,000 | (Feb 13, 2026)
Maestro Tech, Inc. | $1,200,000 | (Feb 13, 2026)
Reflow | $15,000,000 | (Feb 13, 2026)
